Table 3.
Summary of hospital course abdominal X-ray (AXR) and abdominal ultrasound (AUS) findings for patients with and without congenital heart disease (CHD)
| CHD patients (n = 18) [N, %] | Non-CHD patients (n = 68) [N, %] | p valuea | |
|---|---|---|---|
| Findings concerning for ischemic bowel during admission | |||
| Pneumatosis (AXR) | 12(66.7) | 54(79.4) | 0.346 |
| Pneumatosis (AUS) | 6(33.3) | 49(72.1) | 0.005* |
| Portal venous gas (AXR) | 7(38.9) | 15(22.1) | 0.222 |
| Portal venous gas (AUS) | 4(22.2) | 19(27.9) | 0.769 |
| Bowel wall thickening (AUS) | 5(27.8) | 18(26.5) | 0.999 |
| Bowel wall thinning (AUS) | 0(0) | 11(16.2) | 0.110 |
| Echogenic bowel (AUS) | 3(16.7) | 11(16.2) | 0.999 |
| Hyperemic bowel (AUS) | 2(11.1) | 10(14.7) | 0.999 |
| Decreased mural flow (AUS) | 0(0) | 14(20.6) | 0.035* |
| Findings concerning for bowel perforation during admission | |||
| Pneumoperitoneum (AXR) | 2(11.1) | 8(11.8) | 0.999 |
| Pneumoperitoneum (AUS) | 0(0) | 7(10.3) | 0.337 |
| Echogenic free fluid (AUS) | 2(11.1) | 12(17.6) | 0.724 |
| Focal fluid collection (AUS) | 0(0) | 7(10.3) | 0.337 |
CHD congenital heart disease, AXR abdominal X-ray, AUS abdominal ultrasound
*Statistically significant at p < 0.05
aP values refer to results from Fisher’s exact test